JW Pharmaceutical Corp
KRX:001060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
Heartland Express Inc
NASDAQ:HTLD
|
US |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
Beowulf Mining PLC
LSE:BEM
|
UK |
|
N
|
Nova klubburinn hf
ICEX:NOVA
|
IS |
|
O
|
Optimax Holdings Bhd
KLSE:OPTIMAX
|
MY |
Wall Street
Price Targets
Price Targets Summary
JW Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for
JW Pharmaceutical Corp
is 34 680 KRW
with a low forecast of 34 340 KRW and a high forecast of 35 700 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JW Pharmaceutical Corp's stock price target?
Price Target
34 680
KRW
According to Wall Street analysts, the average 1-year price target for
JW Pharmaceutical Corp
is 34 680 KRW
with a low forecast of 34 340 KRW and a high forecast of 35 700 KRW.
What is JW Pharmaceutical Corp's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
JW Pharmaceutical Corp's revenue is
4%.
The projected
CAGR
for the next 3 years is
7%.
What is JW Pharmaceutical Corp's Operating Income forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
JW Pharmaceutical Corp's operating income is
13%.
The projected
CAGR
for the next 3 years is
11%.
What is JW Pharmaceutical Corp's Net Income forecast?
Projected CAGR
21%
The
compound annual growth rate
of JW Pharmaceutical Corp's net income for the next 3 years is
21%.
